论文信息 - Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma - 字舞流文

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

M. Oya | K. Tatsugami | Yoshihiko Tomita | N. Masumori | M. Nozawa | N. Nakaigawa | Y. Miyoshi | T. Osawa | Y. Miura | K. Nishimura | S. Tamada | N. Sassa | Akiko Kimura | S. Kuroda | Hiroomi Kanayama | Y. Tomita